The Evolving Landscape of Drug Therapies for Sickle Cell Disease
Author:
Funder
National Institutes of Health
U.S. Food and Drug Administration
National Heart Lung and Blood Institute
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference109 articles.
1. Sickle-cell disease;Rees;Lancet,2010
2. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates;Piel;Lancet,2013
3. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London;Telfer;Haematologica,2007
4. Sickle cell disease in Africa: a neglected cause of early childhood mortality;Grosse;Am J Prev Med,2011
5. Mortality in sickle cell disease. life expectancy and risk factors for early death;Platt;N Engl J Med,1994
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Newer Modalities and Updates in the Management of Sickle Cell Disease: A Systematic Review;Journal of Blood Medicine;2024-09
2. Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease;Clinical Drug Investigation;2024-08
3. Disease-Modifying Therapies for Sickle Cell Disease—An Overview;Pediatric Annals;2024-02
4. The challenge of clinical end points in sickle cell disease;Blood;2023-12-14
5. Blood rheology and vascular function in sickle cell trait and sickle cell disease: From pathophysiological mechanisms to clinical usefulness;Clinical Hemorheology and Microcirculation;2023-12-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3